These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 26875911)
21. Antifungal agents in children. Steinbach WJ Pediatr Clin North Am; 2005 Jun; 52(3):895-915, viii. PubMed ID: 15925667 [TBL] [Abstract][Full Text] [Related]
22. Role of new antifungal agents in prophylaxis of mycoses in high risk patients. van Burik JA Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials. Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571 [TBL] [Abstract][Full Text] [Related]
24. Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. Bow EJ; Vanness DJ; Slavin M; Cordonnier C; Cornely OA; Marks DI; Pagliuca A; Solano C; Cragin L; Shaul AJ; Sorensen S; Chambers R; Kantecki M; Weinstein D; Schlamm H BMC Infect Dis; 2015 Mar; 15():128. PubMed ID: 25887385 [TBL] [Abstract][Full Text] [Related]
25. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients. Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013 [TBL] [Abstract][Full Text] [Related]
26. Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant. Solano C; Slavin M; Shaul AJ; Marks DI; Cordonnier C; Cornely OA; Pagliuca A; Cragin L; Jarque I; Garcia-Vidal C; Sorensen S; Vanness DJ; Charbonneau C; Barrueta JA; Peral C; De Salas-Cansado M; Bow EJ Mycoses; 2017 Feb; 60(2):79-88. PubMed ID: 27562016 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT. El-Cheikh J; Venton G; Crocchiolo R; Fürst S; Faucher C; Granata A; Oudin C; Coso D; Bouabdallah R; Vey N; Duran S; Fougereau E; Berger P; Chabannon C; Blaise D Bone Marrow Transplant; 2013 Nov; 48(11):1472-7. PubMed ID: 23749104 [TBL] [Abstract][Full Text] [Related]
28. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. Playford EG; Webster AC; Sorrell TC; Craig JC J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344 [TBL] [Abstract][Full Text] [Related]
29. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis. Liu Y; Lan C; Qin S; Qin Z; Zhang Z; Zhang P; Cao W Mycoses; 2022 Oct; 65(10):906-917. PubMed ID: 35899464 [TBL] [Abstract][Full Text] [Related]
34. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections. Cross SA; Scott LJ Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009 [TBL] [Abstract][Full Text] [Related]
35. [Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?]. Salavert M; Jarque I Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():43-9. PubMed ID: 21420577 [TBL] [Abstract][Full Text] [Related]
36. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis. Wang Y; Xie J; Xing Y; Chen L; Li Y; Meng T; Dong W; Wang X; Dong Y Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993334 [TBL] [Abstract][Full Text] [Related]
37. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736 [TBL] [Abstract][Full Text] [Related]
38. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice. Langebrake C; Rohde H; Lellek H; Wolschke C; Kröger NM Clin Transplant; 2014 Mar; 28(3):286-91. PubMed ID: 24479680 [TBL] [Abstract][Full Text] [Related]
39. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials. Wang J; Zhan P; Zhou R; Xu J; Shao X; Yang Y; Ouyang J Med Oncol; 2010 Dec; 27(4):1082-8. PubMed ID: 19876778 [TBL] [Abstract][Full Text] [Related]
40. [Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs]. Yoshida M Nihon Naika Gakkai Zasshi; 2012 Nov; 101(11):3185-91. PubMed ID: 23342592 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]